Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
13Dec2025
  • Home
  • About
  • News
  • Subscribe
13Dec2025
Cost Curve NewsCost Curve News
Cost Curve News

ICER Finalizes Its Approach to Value Assessment. Industry Remains Dissatisfied

The United States does not have a government-sanctioned group that makes determination of the value of a given drug (and it still won’t, even after the Inflation Reduction Act is
costcurvenews
2 years ago
Keep Reading
Cost Curve News

There Are Eye-Popping New 340B Numbers Out from Drug Channels

I would love to write pages and pages about the trove of 340B data that Adam Fein dropped over the weekend, but if you really care about the issue, you
costcurvenews
2 years ago
Keep Reading
Cost Curve News

Industry and Patient Groups Agree: Time Drive Attention to ‘Smoothing’

The “smoothing” provision is the most important part of the IRA that no one has heard of (I mean, you all have heard of it, but I don’t consider any
costcurvenews
2 years ago
Keep Reading
495051

Latest Posts

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

December 8, 2025

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

December 5, 2025

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

December 4, 2025

Popular

A New Tracker for Watching Meds That Might See Prices Slashed

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,939)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,029)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,921)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,717)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,709)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe